PPARA and metabolic dysfunction-associated steatotic liver disease: Unlike Pparg, which can exacerbate MASH progression, knockouts of Ppara are linked to MASLD development, while Pgc1a overexpression reduces hepatic lipid accumulation.35, 36, 37